These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

313 related items for PubMed ID: 8113986

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Nitric oxide regulation of TP receptor-mediated pulmonary vasoconstriction in the anesthetized, open-chest rat.
    Valentin JP, Bessac AM, Maffre M, John GW.
    Eur J Pharmacol; 1996 Dec 19; 317(2-3):335-42. PubMed ID: 8997619
    [Abstract] [Full Text] [Related]

  • 4. Effects of losartan on contractile responses of conductance and resistance arteries from rats.
    Corriu C, Bernard S, Schott C, Stoclet JC.
    J Cardiovasc Pharmacol; 1995 Nov 19; 26(5):688-92. PubMed ID: 8637181
    [Abstract] [Full Text] [Related]

  • 5. AT1 and TxA2/PGH2 receptors maintain hypertension throughout 2K,1C Goldblatt hypertension in the rat.
    Wilcox CS, Cardozo J, Welch WJ.
    Am J Physiol; 1996 Oct 19; 271(4 Pt 2):R891-6. PubMed ID: 8897978
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat.
    Valentin JP, Jover B, Maffre M, Bertolino F, Bessac AM, John GW.
    Am J Hypertens; 1997 Sep 19; 10(9 Pt 1):1058-63. PubMed ID: 9324114
    [Abstract] [Full Text] [Related]

  • 8. Nonpeptide angiotensin II antagonist losartan inhibits thromboxane A2-induced contractions in canine coronary arteries.
    Li P, Ferrario CM, Brosnihan KB.
    J Pharmacol Exp Ther; 1997 Jun 19; 281(3):1065-70. PubMed ID: 9190837
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Sympathetic nervous system and hypertension during prolonged TxA2/PGH2 receptor activation in rats.
    Gao H, Welch WJ, DiBona GF, Wilcox CS.
    Am J Physiol; 1997 Aug 19; 273(2 Pt 2):H734-9. PubMed ID: 9277490
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Endogenous vasoactive systems and the pressor effect of acute N omega-nitro-L-arginine methyl ester administration.
    Nafrialdi N, Jover B, Mimran A.
    J Cardiovasc Pharmacol; 1994 May 19; 23(5):765-71. PubMed ID: 7521459
    [Abstract] [Full Text] [Related]

  • 14. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
    Ogletree ML, Allen GT.
    J Pharmacol Exp Ther; 1992 Feb 19; 260(2):789-94. PubMed ID: 1531361
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Protamine-induced pulmonary hypertension in heparinized monkeys and pigs is inhibited by the thromboxane receptor antagonist SQ 30,741.
    Schumacher WA, Heran CL, Ogletree ML.
    Eicosanoids; 1990 Feb 19; 3(2):87-93. PubMed ID: 2144979
    [Abstract] [Full Text] [Related]

  • 17. Comparative effects of angiotensin II AT-1-type receptor antagonists in vitro on human platelet activation.
    Montón M, Jiménez A, Núñez A, López-Blaya A, Farré J, Gómez J, Zalba LR, Sánchez de Miguel L, Casado S, López-Farré A.
    J Cardiovasc Pharmacol; 2000 Jun 19; 35(6):906-13. PubMed ID: 10836725
    [Abstract] [Full Text] [Related]

  • 18. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
    Schnecko A, Witte K, Lemmer B.
    J Cardiovasc Pharmacol; 1995 Aug 19; 26(2):214-21. PubMed ID: 7475045
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of sympathetic outflow by the angiotensin II receptor antagonist, eprosartan, but not by losartan, valsartan or irbesartan: relationship to differences in prejunctional angiotensin II receptor blockade.
    Ohlstein EH, Brooks DP, Feuerstein GZ, Ruffolo RR.
    Pharmacology; 1997 Nov 19; 55(5):244-51. PubMed ID: 9399334
    [Abstract] [Full Text] [Related]

  • 20. Pharmacological characterization of potent, long-acting thromboxane receptor antagonists, SQ 33,261 and SQ 33,552.
    Harris DN, Michel IM, Goldenberg HJ, Hartl KS, Allen GT, Steinbacher TE, Schumacher WA, Han WC, Hall SE, Floyd DM.
    J Pharmacol Exp Ther; 1992 Apr 19; 261(1):131-7. PubMed ID: 1532833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.